RSS Feeds
Search

Out-licensing

Up-to-date access to technology licensing opportunities worldwide.

Licensing opportunities

Displaying 1..1 of 1 - per page
Order by
Optimised pulmonary and nasal therapies using supercritical fluid (SCF) particle engineering
Supercritical fluid crystal and particle engineering to form particles with strong aerodynamic performance and exceptional size uniformity for optimised pulmonary/nasal delivery More
Displaying 1..1 of 1 - per page
Order by

Related Reports

Market Research Reports provided by reports.iptechex.com
Deals and alliances in dermatological diseases
Jun 2006 - 434 pages - $2,495
Endothelin A Receptor Antagonist (atrasentan) Fails to Demonstrate an Advantage in the Treatment of Advanced Prostate Cancer
May 2011 - 5 pages - $500
Clinical Trial Recruitment in Dermatology - Most Trials Focus on Atopic Dermatitis While Acne Vulgaris Has Highest Patient Numbers
Oct 2011 - 89 pages - $3,500
King III and IT Outsourcing in South Africa
Apr 2011 - 22 pages - $1,895
The Dermatology Market Outlook to 2016
Jul 2011 - 96 pages - $3,835
Medicis Pharmaceutical Corporation: Premium Company Profile
Dec 2007 - 49 pages - $495
The Guide to Distributors of Medical Equipment & Supplies Worldwide 2011 - Regional Volume III: Americas
Feb 2011 - 412 pages - $395
The Impact of King III (Chapter 5) on IT in South Africa
Mar 2011 - 26 pages - $1,895
King III in South Africa: A Practical Implementation Guide
Aug 2011 - 21 pages - $1,895
III. Medizinische Klinik – Developmental Therapeutics Review – Q4 2010
Dec 2010 - 27 pages - $500
More Related Market Research Reports >>>

Your selection

Therapeutic target
Dermatological del
Hyperkeratosis del
Development phase
Phase III/IV del

Browse By

Industry sector
Animal health
Biotechnology
Diagnostic
Drug delivery
Drug discovery
Medical device
Pharmaceutical
Research tools

Clients in focus...

Get the Flash Player to see this rotator.

© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us